115 related articles for article (PubMed ID: 3922085)
1. Destruction of ristocetin cofactor by coagulation at 4 degrees C.
Lloyd JV; Tunbridge LJ; Rodgers SE; Hondow JA; Russell WJ
Thromb Res; 1985 Mar; 37(6):659-68. PubMed ID: 3922085
[TBL] [Abstract][Full Text] [Related]
2. Distribution of plasma fibronectin (cold-insoluble globulin) and components of the factor VIII complex after heparin-induced precipitation of plasma.
Amrani DL; Mosesson MW; Hoyer LW
Blood; 1982 Mar; 59(3):657-63. PubMed ID: 6800421
[TBL] [Abstract][Full Text] [Related]
3. Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC).
Tran TH; Lämmle B; Duckert F
Am J Clin Pathol; 1984 Nov; 82(5):565-72. PubMed ID: 6437209
[TBL] [Abstract][Full Text] [Related]
4. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of factor VIII antigen by means of a simple slide test.
Casonato A; Fabris F; Vicariotto M; Girolami A
Am J Clin Pathol; 1985 Jul; 84(1):107-11. PubMed ID: 3925753
[TBL] [Abstract][Full Text] [Related]
6. Immunological evidence that human factor VIII is composed of two linked moieties.
Koutts J; Lavergne JM; Meyer D
Br J Haematol; 1977 Nov; 37(3):415-28. PubMed ID: 341960
[TBL] [Abstract][Full Text] [Related]
7. [Factor VIII complex activities in acute leukemia].
Pniejnia-Olszyński W; Lopaciuk S
Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320
[TBL] [Abstract][Full Text] [Related]
8. The separation of Willebrand factor from factor VIII-related antigen.
Barrow ES; Reisner HM; Graham JB
Br J Haematol; 1979 Jul; 42(3):455-68. PubMed ID: 314303
[TBL] [Abstract][Full Text] [Related]
9. Factor VIII procoagulant activity, factor VIII related antigen and von Willebrand factor in newborn cord blood.
Fukui H; Takase T; Ikari H; Murakami Y; Okubo Y; Nakamura K
Br J Haematol; 1979 Aug; 42(4):637-46. PubMed ID: 314304
[TBL] [Abstract][Full Text] [Related]
10. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H
Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740
[TBL] [Abstract][Full Text] [Related]
12. Familial incidence of precipitating antibodies in von Willebrand's disease: a study of four cases.
Ruggeri ZM; Ciavarella N; Mannucci PM; Molinari A; Dammacco F; Lavergne JM; Meyer D
J Lab Clin Med; 1979 Jul; 94(1):60-75. PubMed ID: 112210
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
[TBL] [Abstract][Full Text] [Related]
14. Factor VIII complex in myelomatosis and related disorders.
Leone G; Valori VM; Zini G; Bavaro P; Bartoloni C; Bizzi B
Ric Clin Lab; 1982; 12(4):581-8. PubMed ID: 6818670
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of von Willebrand's disease: study of 40 Iranian cases.
Shoa'i I; Lavergne JM; Ardaillou N; Obert B; Ala F; Meyer D
Br J Haematol; 1977 Sep; 37(1):67-83. PubMed ID: 303911
[TBL] [Abstract][Full Text] [Related]
16. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
[TBL] [Abstract][Full Text] [Related]
17. Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration.
Lombardi R; Mannucci PM; Seghatchian MJ; Garcia VV; Coppola R
Br J Haematol; 1981 Sep; 49(1):61-8. PubMed ID: 6791681
[TBL] [Abstract][Full Text] [Related]
18. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
[TBL] [Abstract][Full Text] [Related]
19. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
[TBL] [Abstract][Full Text] [Related]
20. Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin.
Koutts J; Walsh PN; Plow EF; Fenton JW; Bouma BN; Zimmerman TS
J Clin Invest; 1978 Dec; 62(6):1255-63. PubMed ID: 311783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
